Dudediligence.

Precision BioSciences, Inc

DTILNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$466,278

11 notices · 113,001 sh

Oct 2025 to Oct 2026

Reported ·

$466,167

11 sales · 3 buys · $33,714 bought

Oct 2025 to Jun 2026

The two figures cover different periods.

All 11 reported sales carry the 10b5-1 box. Together they are 0.41% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-02-18: SMITH J. JEFFERSON, Form 1442026-02-18: Scimeca Dario, Form 1442026-02-18: Amoroso Michael, Form 1442026-02-18: Kelly John Alexander, Form 1442026-01-22: Amoroso Michael, Form 1442026-01-21: Scimeca Dario, Form 1442026-01-21: SMITH J. JEFFERSON, Form 1442026-01-21: Kelly John Alexander, Form 1442025-11-03: Kelly John Alexander, Form 1442025-11-03: Amoroso Michael, Form 1442025-11-03: Scimeca Dario, Form 1442025-11-03: Amoroso Michael, sold2025-11-03: Scimeca Dario, sold2025-11-03: Kelly John Alexander, sold2025-12-15: Brown Melinda, bought2025-12-16: Frankel Stanley, bought2025-12-16: Germano Geno J, bought2026-01-21: SMITH J. JEFFERSON, sold2026-01-21: Kelly John Alexander, sold2026-01-21: Scimeca Dario, sold2026-01-22: Amoroso Michael, sold2026-02-18: SMITH J. JEFFERSON, sold2026-02-18: Scimeca Dario, sold2026-02-18: Kelly John Alexander, sold2026-02-18: Amoroso Michael, sold
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-02-18SMITH J. JEFFERSON, Chief Research Officer$18,929
4,925 sh10b5-1 plan144 ↗
Form 4, 2026-02-19: sold 4,925 at $3.84 Form 4 ↗
2026-02-18Scimeca Dario, General Counsel and Secretary$18,929
4,925 shplan 2025-09-29144 ↗
Form 4, 2026-02-19: sold 4,925 at $3.84 Form 4 ↗
2026-02-18Amoroso Michael, President and CEO$79,019
20,559 sh10b5-1 plan144 ↗
Form 4, 2026-02-19: sold 20,559 at $3.84 Form 4 ↗
2026-02-18Kelly John Alexander, Chief Financial Officer$31,321
8,149 sh10b5-1 plan144 ↗
Form 4, 2026-02-19: sold 8,149 at $3.84 Form 4 ↗
2026-01-22Amoroso Michael, President and CEO$145,202
34,799 sh10b5-1 plan144 ↗
Form 4, 2026-01-22: sold 34,799 at $4.17 Form 4 ↗
2026-01-21Scimeca Dario, General Counsel and Secretary$35,653
8,854 shplan 2025-09-29144 ↗
Form 4, 2026-01-22: sold 8,854 at $4.03 Form 4 ↗
2026-01-21SMITH J. JEFFERSON, Chief Research Officer$41,073
10,200 sh10b5-1 plan144 ↗
Form 4, 2026-01-22: sold 10,200 at $4.03 Form 4 ↗
2026-01-21Kelly John Alexander, Chief Financial Officer$61,260
15,213 sh10b5-1 plan144 ↗
Form 4, 2026-01-22: sold 15,213 at $4.03 Form 4 ↗
2025-11-03Kelly John Alexander, Chief Financial Officer$8,455
1,303 sh10b5-1 plan144 ↗
Form 4, 2025-11-04: sold 1,303 at $6.49 Form 4 ↗
2025-11-03Amoroso Michael, President and CEO$22,121
3,409 sh10b5-1 plan144 ↗
Form 4, 2025-11-04: sold 3,409 at $6.49 Form 4 ↗
2025-11-03Scimeca Dario, General Counsel and Secretary$4,315
665 shplan 2025-09-29144 ↗
Form 4, 2025-11-04: sold 665 at $6.49 Form 4 ↗